Revolution Medicines Inc. Common Stock vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Revolution Medicines Inc. Common Stock trades at $189.76 (market cap $40.32B), while Direxion Daily Semiconductor Bear 3X Shares trades at $34.39 (market cap $1.96B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 20.6× Direxion Daily Semiconductor Bear 3X Shares's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Direxion Daily Semiconductor Bear 3X Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and Direxion Daily Semiconductor Bear 3X Shares for 11 Days on average.
| RVMD | SOXS | |
|---|---|---|
Market Cap | $40.32B | $1.96B |
Volume | 4,855,734 | 113,512,541 |
Sector | Health | Leveraged / Inverse |
52-Week High | $221.15 | $988.00 |
52-Week Low | $47.50 | $29.62 |
Typical Hold Time | 0 Days | 11 Days |
Enterprise Value | $37.02B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, surged 10.23% to $33.78 amid semiconductor sector volatility. The technical outlook remains bearish with moving averages signaling continued downward pressure, while oscillators show neutral momentum. Recent news highlights SOXS benefiting from semiconductor sell-offs, though analysts caution it's suited only for short-term tactical trades due to extreme volatility and structural decay inherent in leveraged inverse ETFs.
As a leveraged inverse ETF, SOXS carries significant risks including daily rebalancing costs and time decay, making it unsuitable for long-term holdings. The fund thrives during semiconductor downturns but faces headwinds from persistent AI hardware demand. Investors should recognize this as a speculative trading instrument rather than a fundamental investment vehicle.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →